Spain to start producing its own Covid-19 vaccine in OctoberEuropost
The Spanish-made vaccine against Covid-19, created by pharmaceutical company HIPRA, could begin to be produced in October, news wires reported. The news was announced by Science and Innovation Minister Diana Morant, who said that “we could have a Spanish vaccine in early 2022”.
Spain’s medicines agency approved the first round of clinical trials on humans for the new vaccine in August, and at the press conference, Morant indicated that so far “everything is going very well” in the trials. In her words “it will be a very good vaccine” to help fight the virus, since “it has been designed with different variants in mind and has had very good results against them so far”.
The new vaccine has been created by the pharmaceutical company HIPRA, a leading company in the veterinary sector, which has been converted into producing medicines and vaccines for humans to help alleviate the effects of the Covid-19 pandemic.
The HIPRA vaccine isn’t based on mRNA technology such at the Pfizer and the Moderna or the more traditional vaccine technologies that were used by the AstraZeneca and Johnson & Johnson (Janssen) vaccines, instead, it uses recombinant protein technology. So far, scientists have designed it against the Alpha and Beta variants, but reports have suggested that they could easily use the same technology against the Delta variant as well.